no more compounding tirzepatide 🚨 FDA Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these What is the latest update

A landmark randomized, double-blind, placebo-controlled Phase 2 study conducted in the United States enrolled 338 adults with obesity or overweight conditions across multiple dosing regimens

Most patients choose a day that positions the peak side effect window away from important professional or social commitments

1 Midlife increases in weight promote cardiovascular diseasethe primary cause of death in postmenopausal womenand lead to a greater frequency of menopausal effects such as vasomotor symptoms (VMS), sexual dysfunction, and mood disorders

Working in conjunction with your liver, glutathione helps in the detoxification of harmful metabolites,, Staheli says

The impact of liraglutide on diabetes-related foot ulceration and associated complications in patients with type 2 diabetes at high risk for cardiovascular events: results from the LEADER trial

Synthetic human growth hormone (somatropin) introduces exogenous growth hormone directly into the body